Attached files
| file | filename |
|---|---|
| EX-31.1 - EX-31.1 - AGENUS INC | agen-ex311_378.htm |
| EX-32.1 - EX-32.1 - AGENUS INC | agen-ex321_376.htm |
| EX-31.2 - EX-31.2 - AGENUS INC | agen-ex312_377.htm |
| EX-10.24 - EX-10.24 - AGENUS INC | agen-ex1024_396.htm |
| EX-10.25 - EX-10.25 - AGENUS INC | agen-ex1025_395.htm |
| 10-K - 10-K - AGENUS INC | agen-10k_20151231.htm |
| EX-23.1 - EX-23.1 - AGENUS INC | agen-ex231_492.htm |
EXHIBIT 21.1
SUBSIDIARIES OF AGENUS INC.
Antigenics LLC., a Delaware limited liability company and a wholly-owned subsidiary of Agenus Inc.
Aronex Pharmaceuticals, Inc., a Delaware corporation and a wholly-owned subsidiary of Agenus Inc.
Antigenics Therapeutics Limited, a company organized under the laws of Ireland and a wholly-owned subsidiary of Agenus Inc.
4-AntibodyAG, a joint stock company organized under the laws of Switzerland and a wholly-owned subsidiary of Agenus Inc.
Agenus West, LLC, a Delaware limited liability company and a wholly-owned subsidiary of Agenus Inc. (as of November 3, 2015).
Agenus UK Limited, a private limited company organized under the laws of England and Wales and a wholly-owned subsidiary of Agenus Inc. (as of September 17, 2015).